Deutsch English Français

Contact

EP3727360

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP3727360

EP3727360 - NON-RACEMIC BETA-HYDROXYBUTYRATE COMPOUNDS AND COMPOSITIONS ENRICHED WITH S-ENANTIOMER AND METHODS OF USE [Right-click to bookmark this link]
Status	Examination is in progress Status updated on 07.03.2024 Database last updated on 05.10.2024
Former	Request for examination was made Status updated on 25.09.2020
Former	The international publication has been made Status updated on 29.06.2019
Most recent event Tooltip	06.07.2024	New entry: Reply to examination report
Applicant(s)	For all designated states Axcess Global Sciences, LLC 2040 East Murray Holladay Road, Suite 102 Salt Lake City, Utah 84117 / US
	[N/P]
Former [2020/44]	For all designated states Axcess Global Sicences, LLC 2040 East Murray Holladay Road, Suite 102 Salt Lake City, Utah 84117 / US
Inventor(s)	01 / MILLET, Gary 7810 South Prospector Drive Salt Lake City, Utah 84121 / US
	[2020/44]
Representative(s)	Schwarz & Partner Patentanwälte GmbH Patentanwälte Wipplingerstraße 30 1010 Wien / AT
	[N/P]
Former [2020/44]	Schwarz & Partner Patentanwälte OG Patentanwälte Wipplingerstraße 30 1010 Wien / AT
Application number, filing date	18891741.3	20.11.2018
	[2020/44]
	WO2018US62096
Priority number, date	US201762607578P	19.12.2017 Original published format: US 201762607578 P
	US201815936849	27.03.2018 Original published format: US201815936849
	[2020/44]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO2019125693
	Date:	27.06.2019
	Language:	EN
	[2019/26]
	Type:	A1 Application with search report
	No.:	EP3727360
	Date:	28.10.2020
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 27.06.2019 takes the place of the publication of the European patent application.
	[2020/44]
Search report(s)	International search report - published on:	US	27.06.2019
	(Supplementary) European search report - dispatched on:	EP	23.07.2021
Classification	IPC:	A61K31/047, A61K31/22, A61K45/06, A23L29/00, A23L33/10, A23L33/12, A61K31/19, A61P3/08	[2021/34]
	CPC:	A61K31/19 (EP,US); A23L29/035 (EP,US); A23L33/10 (EP,US); A23L33/12 (EP,US); A23L33/30 (EP,US); A61K47/14 (US); (+) A61K9/14 (US); A61K9/20 (US); A61K9/48 (US); A61P3/08 (EP,US); A23L33/155 (EP,US); A23V2002/00 (EP,US); A23V2250/182 (US); A23V2250/192 (US); A23V2250/1946 (US); A23V2250/7106 (US) (-)
	C-Set:	A23V2002/00, A23V2200/332, A23V2250/186, A23V2250/1944, A23V2250/1946, A23V2250/7106 (EP,US)
	Former IPC [2020/44]	A61K31/047, A61K31/22, A61K45/06
Designated contracting states	AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/44]
Title	German:	NICHT-RACEMISCHE BETA-HYDROXYBUTYRAT-VERBINDUNGEN UND MIT S-ENANTIOMER ANGEREICHERTE ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERWENDUNG	[2020/44]
	English:	NON-RACEMIC BETA-HYDROXYBUTYRATE COMPOUNDS AND COMPOSITIONS ENRICHED WITH S-ENANTIOMER AND METHODS OF USE	[2020/44]
	French:	COMPOSÉS BÊTA-HYDROXYBUTYRATE NON RACÉMIQUES ET COMPOSITIONS ENRICHIES EN L'ÉNANTIOMÈRE S, ET LEURS PROCÉDÉS D'UTILISATION	[2020/44]
Entry into regional phase	30.06.2020	National basic fee paid
	30.06.2020	Search fee paid
	30.06.2020	Designation fee(s) paid
	30.06.2020	Examination fee paid
Examination procedure	30.06.2020	Examination requested [2020/44]
	10.02.2022	Amendment by applicant (claims and/or description)
	06.03.2024	Despatch of a communication from the examining division (Time limit: M04)
	05.07.2024	Reply to a communication from the examining division
Fees paid	Renewal fee
	27.11.2020	Renewal fee patent year 03
	29.11.2021	Renewal fee patent year 04
	28.11.2022	Renewal fee patent year 05
	27.11.2023	Renewal fee patent year 06
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[XI]WO2016123229 (UNIV YALE [US]) [X] 1,2,7,8,12-14 * page 3, line 1 - line 29; claim - * [I] 3,6,9-11,15;
		[A]US2017296501 (LOWERY RYAN [US], et al) [A] 1-15* the whole document *;
		[XI] - RHO J M ET AL, "ACETOACETATE, ACETONE, AND DIBENZYLAMINE (A CONTAMINANT IN L-(+)-BETA-HYDROXYBUTYRATE) EXHIBIT DIRECT ANTICONVULSANT ACTIONS IN VIVO", EPILEPSIA, RAVEN PRESS LTD, NEW YORK , US, (20020401), vol. 43, no. 4, doi:10.1046/J.1528-1157.2002.47901.X, ISSN 0013-9580, pages 358 - 361, XP001100603 [X] 1,2,8,12-14 * the whole document * [I] 3-7,9-11,15 DOI: http://dx.doi.org/10.1046/j.1528-1157.2002.47901.x
		[XI] - HACES M L ET AL, "Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions", EXPERIMENTAL NEUROLOGY, ELSEVIER, AMSTERDAM, NL, vol. 211, no. 1, doi:10.1016/J.EXPNEUROL.2007.12.029, ISSN 0014-4886, (20080501), pages 85 - 96, (20080126), XP022633636 [X] 1,2,8,12-15 * the whole document * [I] 3-7,9-11 DOI: http://dx.doi.org/10.1016/j.expneurol.2007.12.029
	International search	[A]US8642654 (CLARKE KIERAN [GB], et al) [A] 1-3, 19 * ; entire document *;
		[X]WO2016123229 (UNIV YALE [US]) [X] 1-3, 19 * ; entire document, especially claims 1-2, claims 5-6, pg 2 line 30 - pg 3 line 5, pg 16 lines 31-34, pg 22 lines 20-27, pg 31 lines 29-34 *;
		[A]US2017258745 (MILLET GARY [US]) [A] 1-3, 19* ; entire document *;
		[A]US2017296501 (LOWERY RYAN [US], et al) [A] 1-3, 19 * ; entire document *
	by applicant	WO2016123229
		US2017296501
		- RHO et al., "Acetoacetate, acetone, and dibenzylamine (a contaminant in 1-(+)-beta-hydroxybutyrate) exhibit direct anticonvulsant actions in vivo", Epilepsia, (20020000), vol. 43, no. 4, doi:10.1046/j.1528-1157.2002.47901.x, pages 358 - 61, XP001100603 DOI: http://dx.doi.org/10.1046/j.1528-1157.2002.47901.x
		- HACES et al., "Antioxidant capacity contributes to protection of ketone bodies against oxidative damage induced during hypoglycemic conditions", Exp Neurol, (20080000), vol. 211, no. 1, doi:10.1016/j.expneurol.2007.12.029, pages 85 - 96, XP022633636 DOI: http://dx.doi.org/10.1016/j.expneurol.2007.12.029

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 34p